Thermo Fisher Scientific agrees to buy Patheon for $7.2bn

US based company Thermo Fisher Scientific has agreed to acquire Patheon, a Dutch contract development and manufacturing organisation (CDMO) for $7.2bn.

Source: Pharmaceutical Technology - May 15, 2017 Category: Pharmaceuticals Source Type: news